HMN-176

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2003-2009
012320032009

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2009
2009
HMN-176 is a potential new cancer therapeutic known to retard the proliferation of tumor cell lines. Here, we show that this… (More)
  • table 1
  • figure 1
  • table 2
  • figure 2
  • figure 3
Is this relevant?
2006
2006
PURPOSE HMN-214 is an oral prodrug of HMN-176, a stilbene derivative that interferes with the subcellular spatial location of… (More)
  • figure 1
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?
2004
2004
HMN-176, (E)-4-{2-[2-(N-[4-methoxybenzene-sulfonyl]amino)phenyl]ethenyl} pyridine 1-oxide, is a stilbene derivative which… (More)
  • figure 1
  • figure 2
  • table 1
  • table 2
  • table 3
Is this relevant?
2004
2004
3034 Background: HMN-176 is a stilbazole derivative with potent antitumor activity in preclinical models. HMN-176 interferes with… (More)
Is this relevant?
2003
2003
HMN-176 ((E)-4-[[2-N-[4-methoxybenzenesulfonyl]amino]stilbazole]1-oxide) is an active metabolite of HMN-214 ((E)-4-[2-[2-(N… (More)
  • figure 1
  • table 1
  • figure 2
  • figure 4
  • figure 3
Is this relevant?
2003
2003
The cytotoxic effects of HMN-176 ((E)-4-{[2-N-[4-methoxybenzenesulfonyl] amino] stilbazole} 1-oxide; Figure 1}, a newly… (More)
Is this relevant?
2003
2003
HMN-176 ((E)-4-{[2-N-[4-methoxybenzenesulfonyl]amino]stilbazole}1oxide) is an active metabolite of HMN-214 ((E)-4-{2-[2-(N-acetyl… (More)
  • figure 1
  • table 1
  • figure 2
  • figure 4
  • figure 3
Is this relevant?